Cargando…
Evaluation of antifungal susceptibility in clinical isolates of the Candida glabrata complex
INTRODUCTION: Candida glabrata is classified as an emerging threat due to its resistance profile to antifungal drugs. Associated to this, there is also the fact that recently, new species of Candida sp. phylogenetically related to Candida glabrata have been discovered: Candida bracarensis and Candid...
Autores principales: | Jesus, Filipa, Barroso, Helena, Nascimento, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480598/ http://dx.doi.org/10.1080/07853890.2021.1895583 |
Ejemplares similares
-
Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
por: Andersen, Kari-Mette, et al.
Publicado: (2016) -
In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST
por: Fatahinia, Mahnaz, et al.
Publicado: (2020) -
Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate
por: Mota, Sandra, et al.
Publicado: (2015) -
Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis
por: Kiasat, Neda, et al.
Publicado: (2019) -
Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
por: Martínez-Herrera, Erick, et al.
Publicado: (2021)